Intelligence · Clinical Development
Pipeline search results
Programs matching “dupilumab” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 62 pipeline programs matching "dupilumab" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Dupilumab
Regeneron UK Limited
Atopic Keratoconjunctivitis
1 trial -
Dupilumab
Regeneron UK Limited
Colitis Ulcerative
1 trial -
Dupilumab
Regeneron UK Limited
Eosinophilic Gastritis (EoG)
1 trial -
Dupilumab
Regeneron UK Limited
Prostate Cancer
1 trial -
Dupilumab
Regeneron UK Limited
Pruritis
1 trial -
Dupilumab
CATALYST PHARMACEUTICALS, INC.
COVID-19
1 trial -
Dupilumab
Coherus Oncology
Metastatic Colorectal Cancer
1 trial -
Dupilumab (blinded)
Regeneron UK Limited
Eosinophilic Gastritis
1 trial -
Dupilumab 300Mg Solution for Injection
Regeneron UK Limited
Pruritus
1 trial -
Placebo (for dupilumab)
Regeneron UK Limited
Nasal Polyps
1 trial -
dupilumab
Regeneron UK Limited
Allergic Bronchopulmonary Aspergillosis
1 trial -
dupilumab
Regeneron UK Limited
Chronic Sinusitis
1 trial -
Dupilumab
Regeneron UK Limited
Atopic Disorders
1 trial -
Dupilumab (SAR231893)
Regeneron UK Limited
Healthy Volunteer
1 trial -
Dupilumab (SAR231893)
Regeneron UK Limited
Healthy Volunteers
2 trials -
Dupilumab
Regeneron UK Limited
Atopic Dermatitis
16 trials -
Dupilumab
Regeneron UK Limited
Asthma
13 trials -
Dupilumab
Regeneron UK Limited
Eosinophilic Oesophagitis
1 trial -
Dupilumab
Regeneron UK Limited
Allergic Contact Dermatitis
1 trial -
Dupilumab
Regeneron UK Limited
Keloid
2 trials -
Dupilumab
Sanofi Pasteur
Asthma
2 trials -
Dupilumab
Regeneron UK Limited
Dermatitis, Atopic
5 trials -
Dupilumab
Regeneron UK Limited
Eczema
1 trial -
Dupilumab
Regeneron UK Limited
Chronic Rhinosinusitis With Nasal Polyps
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.